Successful Use of Denosumab for Life-Threatening Hypercalcemia in a Pediatric Patient with Primary Hyperparathyroidism
Conclusion: Our case supports the previous observations in adults that denosumab can be safely and effectively used as a preoperative treatment in patients with PHPT and severe hypercalcemia and shows that it may be used in pediatric patients.Horm Res Paediatr
Source: Hormone Research in Paediatrics - Category: Endocrinology Source Type: research
More News: Calcium | Children | Endocrinology | Genetics | Hormones | Hyperparathyroidism | Orthopaedics | Osteoporosis | Parathyroidectomy | Pediatrics | Weight Loss | Xgeva